Living Donation Week 2020 – Spotlight Sessions: Under privileged populations
Do not miss CDTRP’s investigators and patient-partners’ sessions at the Living Donation Week 2020: “Improving Access to Liver Transplantation in Diverse Communities” and “The Future of Transplantation and Living donation.”
See more information about Living Donation Week 2020 here
A.C.T.I.O.N.: Improving access and equity in Living Donor Kidney Transplantation in ACB & South Asian Communities
Monday, September 14 at 11:10am ET
Living Donation week begins with Access & Equity in Living Kidney Donation & Transplantation. Building on the work of the A.C.T.I.O.N. Project, led by Dr. Istvan Mucsi, UHN and Dr. Jag Gill, Providence Health Care, this panel will discuss barriers to living donor kidney transplantation (LDKT) in Canada and internationally.
Access to LDKT is dramatically reduced among ethno-racial minority groups in Canada and other parts of the world. To date, no interventions to address these inequities have been carried out in Canada. A.C.T.I.O.N. aims to identify barriers to LDKT for African, Caribbean and Black (ACB) communities in Ontario, and South Asian Communities in B.C.
The first seminar of the week is divided into two parts. Part one, chaired by Dr. Istvan Mucsi, will examine international perspectives on access and equity to LDKT.
Part two, chaired by Dr. Sunita Singh, Medical Director of the Living Kidney Donor Program at UHN, will discuss improving access and equity to LDKT in the Canadian context.
Speaker Spotlight: Dr. Istvan Musci
Istvan Mucsi, MD, PhD is a CIHR funded clinician investigator, transplant nephrologist at the Multi-Organ Transplant Program and Division of Nephrology at the University Health Network in Toronto. He is an Associate Professor of Medicine at University of Toronto. Dr. Mucsi is an “expert advisor” of the Canadian Donation and Transplant Research Program.
He received his medical degree (1988) and his certification in internal medicine (1993) in Budapest, Hungary and completed nephrology training at the University of Toronto (1994-1997). Initially he had been working as a general nephrologist but later moved to Montreal to work as a transplant nephrologist at McGill University. He has moved to Toronto in April 2014.
His current research focuses on understanding and reducing ethnocultural barriers and disparities in access to kidney transplantation and living donor kidney transplantation. He has been collaborating with multiple community agencies and religious organizations develop culturally and religiously competent kidney transplant education for multiple ethnocultural communities in Ontario.
He has adapted a patient education program, called Explore Transplant, for use in Ontario. This program is a key educational tool in the Enabling Access to Kidney Transplant-Living Kidney Donation (ENAKT-LKD) provincial initiative managed by the Ontario Renal Network and Trillium Gift of Life Network. Dr. Mucsi has been co-leading the education pillar of that initiative.
He also has a strong interest in psychosocial determinants of health; sleep disorders; quality of life studies and patient reported outcomes. Dr. Mucsi will test the effectiveness of routinely measuring Patient Reported Outcome Measures in the everyday clinical care of patients with chronic kidney disease and solid organ transplant recipients, to improve clinical and quality of life outcomes.
He published more than one 140 peer reviewed articles, his H index is 46.
Register for free to this session here: ACTION: Improving access and equity in Living Donor Kidney Transplantation
Living Donor Kidney Transplantation & Indigenous Communities (AM5)
Friday, September 18 at 9:00am ET
…
Speaker Spotlight: Mary Beaucage
Hailing from Nipissing First Nation near North Bay ON, Mary Beaucage is Anishnaabekwe. She lives with Chronic Kidney Disease and received a living donor transplant from her cousin, who lives in Northern Manitoba. Mary received her cousin’s gift at Toronto General Hospital (TGH) in 2015. Since her transplant, Mary has been active in patient engagement. She brings a wealth of knowledge, enthusiasm and passion to her work in educating and advocating in matters of Indigenous health, CKD research, and organ donation and transplantation awareness.
Mary has been involved with Can-SOLVE CKD since 2016. She’s recently accepted the role of co-chair of the Indigenous Peoples Engagement Research Council (IPERC), and has been a key contributor to IPERC’s efforts to ensure Indigenous knowledge and perspectives are incorporated into all aspects of the Can-SOLVE CKD Network, and currently sits on the Wabishki Bizkiko Skaanj Learning Pathway Working Group, which enhances researchers knowledge and awareness of racial biases, Indigenous voices and stories, the impact of colonization on Indigenous health, and culturally safe research practices.
In addition to her roles with IPERC, Mary is engaged in a wide range of activities across the Can-SOLVE CKD Network. She is a co-chair of the Patient Governance Circle (PGC) and sits on several committees.Mary is also a patient partner on four Can-SOLVE CKD research project teams. Mary has leadership roles with provincial level PFACs at Ontario Health, including the Ontario Renal Network(ORN), and is also involved with the Canadian Donation Transplant Research Program (CDTRP), The Kidney Foundation of Canada (KFoC), the Organ Donation and Transplantation Collaborative (ODTC), and the Internationals Society of Nephrology (ISN) in the areas of equity, patient partnership and public awareness.
Mary is currently a Provincial Coordinator with the Transplant Ambassador Program (TAP), which is a research project bringing CKD patients together with kidney recipients and living donors to share stories, and increase education regarding living kidney donation. TAP is one of the 18 research projects in the Can-SOLVE CKD Network, as well as a pillar of the Enabling Access to Kidney Transplant-Living Kidney Donation (ENAKT-LKD), a provincial initiative managed by the ORN and Trillium Gift of Life Network (TGLN).
She has been a keynote speaker, presented on panels, and has had her poster on “Patient Engagement in Knowledge Translation (KT)” presented at nephrology conferences nationally and internationally. Mary has found strength in talking to others and feels it’s vital to share lived experiences through her culture of Indigenous storytelling, to give all stakeholders a clear perspective of the patient journey.
Register for free to this session here: Living Donor Kidney Transplantation & Indigenous Communities
ity of Alberta and has received training in patient-oriented research through the University of Calgary’s PACER (Patient and Community Engagement Research) Program. He is the Patient, Family, and Donor Partnerships & Education Manager with the Canadian Donation and Transplantation Research Program. In this role, Manuel builds relationships patient partners with investigators and strengthens capacity among CDTRP patient partners.
Anders Billström 
Gareth Wiltshire
K
Sherrie Logan 
born and raised in Edmonton, AB. With a degree in Music Performance (saxophone performance) and Education, Lindsey has taught for over a decade in the Edmonton Public School system. When she is not teaching, she is very involved in the music community, performing in the Edmonton Winds, conducting her own community ensemble (The Beer League Band) and on numerous musical boards across the province. For the past 5 years, Lindsey has had to take a break from teaching after having her amazing son, George. Maternity leave did not goes as expected as George was diagnosed with Dilated Cardiomyopathy at 5 months old and required 2 heart transplants before the age of 4. During this time, Lindsey has also began to dedicate her time building and expanding her charity: Big Gifts for Little Lives, where they raise money to fund Pediatric Heart Transplant research at the Stollery.
Dr. Caigan Du is a scientist at the Vancouver Coastal Health Research Institute and an assistant professor in the Department of Urologic Sciences at the University of British Columbia. He received a Ph.D. degree in Biochemistry in UK and postdoctoral training in Immunology in USA. He is interested in the pathogenesis of kidney ischemia-reperfusion injury and transplant rejection, and molecular control of urinary malignancies. He has been studying the impact of kidney donor-derived factors on renal allograft rejection, and the molecular pathways of kidney injury and regeneration in experimental models. He is also interested in developing medical solution including drugs made from natural compounds for all kinds of health problems, including immune disorders, organ preservation, kidney failure and urinary cancer. He is the PI of many grant supports from the Kidney Foundation of Canada and the Canadian Institutes of Health Research.
Heather Badenoch is a non-directed living liver donor and communications strategist. As the president of Village PR, she provides strategic communications direction and training to not-for-profit clients in community and health. An active transplant volunteer, Heather helps transplant candidates find living donors by running their public appeals, small and large, pro-bono. She also mentors potential living donors on the path to living donation. Heather is a volunteer with the UHN Centre for Living Organ Donation and the Canadian Donation and Transplant Research Program. She and her spouse adopt rescue dogs and volunteer together with Community Veterinary Outreach, a group providing free veterinary care to the pets of people who are homeless.
Sean Dicks is a clinical psychologist who has 20 years’ experience supporting both families of organ donors and transplant recipients. While it is rare for him to have contact with a donor family and recipient linked to the same organ donation-transplantation event, his contact with families who have lived experience with organ donation on the one hand, and patients who have received transplants on the other hand has provided opportunities to explore how their journeys become linked when they attempt to make sense of and find meaning in their respective crises.
Terri Hansen-Gardiner is a Cree speaking Metis woman from Northern Saskatchewan as well as a 10 year Breast Cancer Survivor. Her tireless spirit and dedication to her community is undeniable. Terri is a cancer survivor who travels around the province to provide assistance, information, and support to Indigenous patients who are trying to access and navigate the cancer care system.
Dr. Golnaz Karoubi is Assistant Scientist at the Toronto General HospitalResearch Institute and principal investigator in the Latner Thoracic Research Labs. She currently holds an Assistant Professor appointment in the department of Laboratory Medicine and Pathobiology and a cross-appointment in the department of Mechanical and Industrial Engineering at the University of Toronto. Dr. Karoubi received her PhD in Applied Science and Engineering at the University of Toronto and joined the Lung Regenerative Medicine Program in the Department of Clinical Research in Berne University, Switzerland for a post-doctoral research fellowship. She stayed on as a Group Leader in 2008 to direct the basic and transitional science as related to Cancer Stem Cell and Lung Regenerative Medicine in the Department of Biomedical Research at the University of Berne until 2012. In early 2012, she joined the team of Dr. Tom Waddell at the Toronto General Hospital Research Institute as a Senior Scientific Associate and was appointed to Assistant Scientist at the Toronto General Hospital Research Institute (University Health Network) in November 2019 and to Assistant Professor in the Department of Laboratory Medicine and Pathobiology in July 2020.
Dr. Haykal graduated from the University of Ottawa Faculty of Medicine in2007 as class valedictorian and silver medalist, and subsequently completed her residency training in Plastic and Reconstructive Surgery at the University of Toronto in 2016. During her residency, she completed a four-year Doctorate of Philosophy (PhD) in tissue engineering, regenerative medicine and immunology with a focus on tracheal reconstruction. She obtained numerous grants and awards including a CIHR Vanier Scholarship. Dr. Haykal then pursued fellowship training in microsurgical reconstruction at the Albany Medical Centre in New York. Dr. Haykal joined the University Health Network and the Toronto General Hospital in 2018. Her clinical focus is on complex oncological reconstruction and microsurgical reconstruction of the breast, head and neck and extremity. She started a lymphedema program in 2019 where she offers microsurgical techniques for the treatment of lymphedema.
Dr. Ahmed is a Professor in the Cumming School of Medicine at the University of Calgary. The recipient of the 2022 Hypertension Canada Senior Investigator Award, she is a nephrologist and clinician-scientist with a focus on sex and gender differences in human cardiovascular/kidney physiology and clinical outcomes. Dr. Ahmed is the Vice Chair (Research) for the Department of Medicine, Lead of the Libin Institute Women’s Cardiovascular Health Research Initiative at the University of Calgary and Lead of the Alberta Strategy for Patient Oriented Research Capacity Development Platform. Dr. Ahmed is an Advisory Board member for the Canadian Institutes of Health Research Institute of Gender and Health, a member of the Canadian Medical Association Journal Governing Council and the President-Elect for the Organization for the Study of Sex Differences.
r. Christopher Nguan is an Associate Professor at the University of British Columbia in the Department of Urological Sciences, Surgical Head of Kidney Transplantation at Vancouver General Hospital and the Director of the Surgical Technologies Experimental Laboratory & Advanced Robotics (STELLAR) facility at Vancouver General Hospital.
r Caroline Lamarche is a clinician scientist and transplant nephrologist at Maisonneuve-Rosemont Hospital. She is an assistant clinical professor at the Université de Montréal. After her nephrology training at the Université de Montréal (2015), she completed a Master degree on the use of adoptive immunotherapy to treat/prevent BK nephropathy in kidney transplant recipients. She then pursued a post-doctoral fellowship with Dr. Megan Levings at the University of British Columbia on the use of chimeric antigen receptor (CAR) regulatory T cells (Tregs) to induce transplant tolerance. Her lab is working on the development of adoptive immunotherapy in nephrology and understanding Treg dysfunction.
Dr. Tandon is an Associate Professor of Medicine, Co-Director of the Cirrhosis Care Clinic, Transplant Hepatologist and lead of the Cirrhosis Care Alberta quality improvement program. She obtained her training at the University of Alberta, the Hospital Clinic in Barcelona and Yale University. Her clinical practice and research are focused on cirrhosis with research interests including cirrhosis related complications, malnutrition, frailty, exercise therapy, palliative care, integrative health approaches such as meditation and knowledge translation. It is her career goal to provide wholistic, interdisciplinary, evidence based, patient-centered care through education, empowerment, engagement and team-work.
Emily is a PhD student at the University of Alberta, where she completed her Master of Science (MSc) degree in medicine. With a passion for patient-oriented research and a commitment to improving health outcomes, Emily’s doctoral project focuses on EMPOWER, a 12-week online mind-body wellness program designed for adults living with chronic health conditions.
Dr Basil S. Nasir, M.B.B.Ch
Dr. Victor Ferreira is an Assistant Scientist in the Ajmera Transplant Centre at the University Health Network (UHN) and the Toronto General Hospital Research Institute (TGHRI). He is also an Assistant Professor at the University of Toronto in the Department of Laboratory Medicine and Pathobiology (LMP). He completed his PhD in Medical Sciences – Infection and Immunity Specialization at McMaster University in 2014 and post-doctoral training at UHN. His research program is focused on three pillars: I) using systems vaccinology to reveal insights into vaccine responses in immunocompromised individuals like transplant recipients; II) characterizing the impact of chronic viral infection on host immune responses; and III) developing novel methods for eliminating latent viruses in human organs. His work has been cited >2,500 times and is published in journals including the New England Journal of Medicine, Nature Immunology, the Lancet Infectious Diseases, Clinical Infectious Diseases, the American Journal of Transplantation and Journal of Infectious Diseases.
Chemical Engineering as an Assistant Professor in August 2014. She is a biochemical engineer with expertise in bioprocess development, high‑throughput screening and stem cell culture optimization. Her research aims to develop bioprocesses to produce and transplant therapeutic cells to treat diabetes and cardiovascular disease. She notably developed new methods to encapsulate pancreatic islets, as well as vascular biomaterials surface modification strategies which are now applied by other researchers around the world. Her emerging leadership in bioengineering was recognized through the 2014 Martin Sinacore Outstanding Young Investigator Award from Engineering Conferences International & Biogen Idec, as well as the “Étoiles effervescence” award from Montreal InVivo.
